References
- Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010;362:1804-13
- Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 2014;20:1170-5
- Giske CG, Monnet DL, Cars O, et al. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008;52:813-21
- Trecarichi EM, Cauda R, Tumbarello M. Detecting risk and predicting patient mortality in patients with extended-spectrum beta-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiol 2012;7:1173-89
- Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81
- Vasoo S, Barreto JN, Tosh PK. Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician. Mayo Clin Proc 2015;90:395-403
- European Centre for Disease Prevention and Control. Carbapenemase-producing bacteria in Europe: interim results from the European Survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE) project. Stockholm: European Centre for Disease Prevention and Control, 2013
- Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005;352:380-91
- Dhariwal AK, Tullu MS. Colistin: re-emergence of the ‘forgotten’ antimicrobial agent. J Postgrad Med 2013;59:208-15
- Velkov T, Roberts KD, Nation RL, et al. Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics. Future Microbiol 2013;8:711-24
- Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41
- Lepape A, Monnet DL, participating members ESoICM. Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009. Euro Surveill 2009;14:19393
- Allison PD. Logistic Regression Using SAS: Theory and Application, 2nd edn. Cary (NC): SAS Institute Inc., 2012
- Infectious Diseases Society of America; Spellberg B, Blaser M, Guidos RJ, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011;52(Suppl 5):S397-428
- Hoffman SJ, Outterson K, Rottingen JA, et al. An international legal framework to address antimicrobial resistance. Bull World Health Organ 2015;93:66
- Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014;20(Suppl 1):1-55
- World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization, 2015
- European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm: European Centre for Disease Prevention and Control, 2015